Alzheimer’s latest drug and science journalism’s memory problem

In July, the medical community was rocked by a disappointing reminder of science’s weakest link: the humans doing the work. The journal Science had shared that its six-month investigation supported the findings of whistleblower Matthew Schrag, who first noted altered images in a high-impact paper on Alzheimer’s, published in Nature in 2006. That paper is still flagged on Nature as under review, but the damage has already been done. Alzheimer’s drugs for the last decade and a half have been developed around claims without as much evidence as initially believed—which might also explain why they haven’t been working, leading people to pour false hope into useless and often expensive treatment plans for declining loved ones.

Alzheimer’s latest drug and science journalism’s memory problem

Health Insurance Whistleblower: Medicare Advantage Is “Heist” by Private Firms to Defraud the Public

Many of the nation’s largest health insurance companies have made billions of dollars in profits by overbilling the U.S. government’s Medicare Advantage program. A New York Times investigation has revealed that under the Advantage program, health insurance companies are incentivized to make patients appear more ill than they actually are. Some estimates find it has cost the government between $12 billion and $25 billion in 2020 alone. We speak with former healthcare insurance executive Wendell Potter, now president of the Center for Health and Democracy, who says Medicare Advantage will be recognized in years to come as the “biggest transfer of wealth” from taxpayers to corporate shareholders, and blames the lack of regulation over the program on the “revolving door between private industry and government.”

Health Insurance Whistleblower: Medicare Advantage Is “Heist” by Private Firms to Defraud the Public

Related:

‘The Cash Monster Was Insatiable’: How Insurers Exploited Medicare for Billions (archived)